Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caligiuri

Showing results (901-910 of 1,066) with videos related to

Pageof 107
Sort By:
Nature Communications|May 13, 2022
Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19Ting Lu, Rui Ma, Wenjuan Dong, et al.
Vaccines|June 2, 2021
Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative DiseaseElshafa Hassan Ahmed, Eric Brooks, Shelby Sloan, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 17, 2024
The localization, origin, and impact of platelets in the tumor microenvironment are tumor type-dependentOphélie Le Chapelain, Soumaya Jadoui, Angèle Gros, et al.
Immunity|May 15, 2016
A Progenitor Cell Expressing Transcription Factor RORγt Generates All Human Innate Lymphoid Cell SubsetsSteven D Scoville, Bethany L Mundy-Bosse, Michael H Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2016
Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell ImmunotherapyJi Young Yoo, Alena Cristina Jaime-Ramirez, Chelsea Bolyard, et al.
Circulation|January 2, 2015
Control of the T follicular helper-germinal center B-cell axis by CD8⁺ regulatory T cells limits atherosclerosis and tertiary lymphoid organ developmentMarc Clement, Kevin Guedj, Francesco Andreata, et al.
Immunity|March 15, 2015
Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and functionYoucai Deng, Yann Kerdiles, Jianhong Chu, et al.
Blood|May 13, 2010
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibodyDon M Benson, Courtney E Bakan, Anjali Mishra, et al.
Blood|June 2, 2021
Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemiaCaroline Duault, Anil Kumar, Adeleh Taghi Khani, et al.
Science (New York, N.Y.)|June 6, 2024
A master regulator of opioid reward in the ventral prefrontal cortexAlexander C W Smith, Soham Ghoshal, Samuel W Centanni, et al.
Pageof 107

Showing results (901-910 of 1,066) with videos related to

Sort By:
Pageof 107
Nature Communications|May 13, 2022
Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19Ting Lu, Rui Ma, Wenjuan Dong, et al.
Vaccines|June 2, 2021
Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative DiseaseElshafa Hassan Ahmed, Eric Brooks, Shelby Sloan, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 17, 2024
The localization, origin, and impact of platelets in the tumor microenvironment are tumor type-dependentOphélie Le Chapelain, Soumaya Jadoui, Angèle Gros, et al.
Immunity|May 15, 2016
A Progenitor Cell Expressing Transcription Factor RORγt Generates All Human Innate Lymphoid Cell SubsetsSteven D Scoville, Bethany L Mundy-Bosse, Michael H Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2016
Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell ImmunotherapyJi Young Yoo, Alena Cristina Jaime-Ramirez, Chelsea Bolyard, et al.
Circulation|January 2, 2015
Control of the T follicular helper-germinal center B-cell axis by CD8⁺ regulatory T cells limits atherosclerosis and tertiary lymphoid organ developmentMarc Clement, Kevin Guedj, Francesco Andreata, et al.
Immunity|March 15, 2015
Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and functionYoucai Deng, Yann Kerdiles, Jianhong Chu, et al.
Blood|May 13, 2010
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibodyDon M Benson, Courtney E Bakan, Anjali Mishra, et al.
Blood|June 2, 2021
Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemiaCaroline Duault, Anil Kumar, Adeleh Taghi Khani, et al.
Science (New York, N.Y.)|June 6, 2024
A master regulator of opioid reward in the ventral prefrontal cortexAlexander C W Smith, Soham Ghoshal, Samuel W Centanni, et al.
Pageof 107